[Prognosis of adult non-Hodgkin's lymphomas. Retrospective study of sixty-six patients (author's transl)].
The authors studied the prognosis of 66 adults NHL according to: histological, clinical, biological and evolution criteria. The patients were treated by polychemotherapy or polychemo-and radiotherapy. Three years actuarial survival compared by the X2 test permits to consider only two independent prognostic factors: histologic type and complete remission due to treatment.